The Dubai Health Authority (DHA) has approved a 10-week interval between the two doses of the Oxford-AstraZeneca vaccine.
Its decision is based on recent studies by Oxford University as well as the World Health Organisation's (WHO) recommendations.
The DHA said the studies showed a higher efficacy and higher acquired immunity when the dosing interval was increased.
It added that all those who are due for the second dose of this vaccine will receive a text message with the date and location for their vaccination appointment.
Based on recent studies from the University of Oxford on the Oxford-AstraZeneca vaccine and as per the recommendations of the WHO, DHA has approved a 10-week interval between the 1st & 2nd dose of the Oxford-AstraZeneca vaccine. pic.twitter.com/hXzPns7RE6— هيئة الصحة بدبي (@DHA_Dubai) February 23, 2021